These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 11570904)

  • 1. Malignant melanoma.
    Slominski A; Wortsman J; Carlson AJ; Matsuoka LY; Balch CM; Mihm MC
    Arch Pathol Lab Med; 2001 Oct; 125(10):1295-306. PubMed ID: 11570904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of soft tissue and bone tumors. A review.
    Slominski A; Wortsman J; Carlson A; Mihm M; Nickoloff B; McClatchey K
    Arch Pathol Lab Med; 1999 Dec; 123(12):1246-59. PubMed ID: 10583931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor progression in the human melanocytic system.
    Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of tumor progression in human melanocytes.
    Herlyn M; Clark WH; Rodeck U; Mancianti ML; Jambrosic J; Koprowski H
    Lab Invest; 1987 May; 56(5):461-74. PubMed ID: 3553733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
    Reed JA; Loganzo F; Shea CR; Walker GJ; Flores JF; Glendening JM; Bogdany JK; Shiel MJ; Haluska FG; Fountain JW
    Cancer Res; 1995 Jul; 55(13):2713-8. PubMed ID: 7796391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic basis of malignant melanoma].
    Drewa G; Powierska-Czarny J
    Postepy Hig Med Dosw; 1998; 52(4):367-80. PubMed ID: 9780757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis.
    Casorzo L; Luzzi C; Nardacchione A; Picciotto F; Pisacane A; Risio M
    Melanoma Res; 2005 Jun; 15(3):155-60. PubMed ID: 15917696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of mRNA for the melanocortin-1 receptor but not for melanogenic proteins in macrophage x melanoma fusion hybrids exhibiting increased melanogenic and metastatic potential.
    Chakraborty AK; Funasaka Y; Ichihashi M; Sodi S; Bhattacharya M; Pawelek J
    Pigment Cell Res; 1999 Dec; 12(6):355-66. PubMed ID: 10614575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma progression.
    Elder DE
    Pathology; 2016 Feb; 48(2):147-54. PubMed ID: 27020387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma Development: Current Knowledge on Melanoma Pathogenesis.
    Lugović-Mihić L; Ćesić D; Vuković P; Novak Bilić G; Šitum M; Špoljar S
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):163-168. PubMed ID: 31542060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors.
    Mishima Y
    Pigment Cell Res; 1994 Dec; 7(6):376-87. PubMed ID: 7761345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of cytogenetic abnormalities in melanoma.
    Nelson MA; Thompson FH; Emerson J; Aickin M; Adair L; Trent JM; Leong SP; Taetle R
    Surg Clin North Am; 1996 Dec; 76(6):1257-71. PubMed ID: 8977549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of tyrosinase, tyrosinase-related proteins 1 and 2 (TRP1 and TRP2), the silver protein, and a melanogenic inhibitor in human melanoma cells of differing melanogenic activities.
    Kameyama K; Sakai C; Kuge S; Nishiyama S; Tomita Y; Ito S; Wakamatsu K; Hearing VJ
    Pigment Cell Res; 1995 Apr; 8(2):97-104. PubMed ID: 7659683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of melanogenesis in mouse melanoma cells of varying metastatic potential.
    Niles RM; Makarski JS
    J Natl Cancer Inst; 1978 Aug; 61(2):523-6. PubMed ID: 210294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
    Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
    Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
    Sato K; Toriyama M
    J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression.
    Orlow SJ; Hearing VJ; Sakai C; Urabe K; Zhou BK; Silvers WK; Mintz B
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10152-6. PubMed ID: 7479744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma.
    Straume O; Sviland L; Akslen LA
    Clin Cancer Res; 2000 May; 6(5):1845-53. PubMed ID: 10815907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serum/PDGF-dependent "melanogenic" role of the minute level of the oncogenic kinase PAK1 in melanoma cells proven by the highly sensitive kinase assay.
    Be Tu PT; Nguyen BC; Tawata S; Yun CY; Kim EG; Maruta H
    Drug Discov Ther; 2017 Jan; 10(6):314-322. PubMed ID: 27746419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.